Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Coffee, caffeine-related genes, and Parkinson's disease: a case-control study.

Facheris MF, Schneider NK, Lesnick TG, de Andrade M, Cunningham JM, Rocca WA, Maraganore DM.

Mov Disord. 2008 Oct 30;23(14):2033-40. doi: 10.1002/mds.22247.

2.

Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson's disease.

Popat RA, Van Den Eeden SK, Tanner CM, Kamel F, Umbach DM, Marder K, Mayeux R, Ritz B, Ross GW, Petrovitch H, Topol B, McGuire V, Costello S, Manthripragada AD, Southwick A, Myers RM, Nelson LM.

Eur J Neurol. 2011 May;18(5):756-65. doi: 10.1111/j.1468-1331.2011.03353.x. Epub 2011 Jan 31.

3.

An attempt to replicate interaction between coffee and CYP1A2 gene in connection to Parkinson's disease.

Hill-Burns EM, Hamza TH, Zabetian CP, Factor SA, Payami H.

Eur J Neurol. 2011 Sep;18(9):e107-8; author reply e109. doi: 10.1111/j.1468-1331.2011.03464.x. No abstract available.

4.

Polymorphisms of caffeine metabolism and estrogen receptor genes and risk of Parkinson's disease in men and women.

Palacios N, Weisskopf M, Simon K, Gao X, Schwarzschild M, Ascherio A.

Parkinsonism Relat Disord. 2010 Jul;16(6):370-5. doi: 10.1016/j.parkreldis.2010.02.012. Epub 2010 Mar 20.

5.

Caffeine and Parkinson's disease: are we getting our fix on risk-modifying gene-environment interactions?

Mellick GD, Ross OA.

Eur J Neurol. 2011 May;18(5):671-2. doi: 10.1111/j.1468-1331.2011.03350.x. Epub 2011 Jan 31. No abstract available.

PMID:
21281404
6.

Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffee.

Hamza TH, Chen H, Hill-Burns EM, Rhodes SL, Montimurro J, Kay DM, Tenesa A, Kusel VI, Sheehan P, Eaaswarkhanth M, Yearout D, Samii A, Roberts JW, Agarwal P, Bordelon Y, Park Y, Wang L, Gao J, Vance JM, Kendler KS, Bacanu SA, Scott WK, Ritz B, Nutt J, Factor SA, Zabetian CP, Payami H.

PLoS Genet. 2011 Aug;7(8):e1002237. doi: 10.1371/journal.pgen.1002237. Epub 2011 Aug 18.

7.

Genome-wide association analysis of coffee drinking suggests association with CYP1A1/CYP1A2 and NRCAM.

Amin N, Byrne E, Johnson J, Chenevix-Trench G, Walter S, Nolte IM; kConFab Investigators, Vink JM, Rawal R, Mangino M, Teumer A, Keers JC, Verwoert G, Baumeister S, Biffar R, Petersmann A, Dahmen N, Doering A, Isaacs A, Broer L, Wray NR, Montgomery GW, Levy D, Psaty BM, Gudnason V, Chakravarti A, Sulem P, Gudbjartsson DF, Kiemeney LA, Thorsteinsdottir U, Stefansson K, van Rooij FJ, Aulchenko YS, Hottenga JJ, Rivadeneira FR, Hofman A, Uitterlinden AG, Hammond CJ, Shin SY, Ikram A, Witteman JC, Janssens AC, Snieder H, Tiemeier H, Wolfenbuttel BH, Oostra BA, Heath AC, Wichmann E, Spector TD, Grabe HJ, Boomsma DI, Martin NG, van Duijn CM.

Mol Psychiatry. 2012 Nov;17(11):1116-29. doi: 10.1038/mp.2011.101. Epub 2011 Aug 30.

8.

Association between caffeine intake and risk of Parkinson's disease among fast and slow metabolizers.

Tan EK, Chua E, Fook-Chong SM, Teo YY, Yuen Y, Tan L, Zhao Y.

Pharmacogenet Genomics. 2007 Nov;17(11):1001-5.

PMID:
18075470
9.

Gene-Environment Interaction in Parkinson's Disease: Coffee, ADORA2A, and CYP1A2.

Chuang YH, Lill CM, Lee PC, Hansen J, Lassen CF, Bertram L, Greene N, Sinsheimer JS, Ritz B.

Neuroepidemiology. 2016;47(3-4):192-200. doi: 10.1159/000450855. Epub 2016 Jan 31.

10.

Gender and ethnicity modify the association between the CYP1A2 rs762551 polymorphism and habitual coffee intake: evidence from a meta-analysis.

Denden S, Bouden B, Haj Khelil A, Ben Chibani J, Hamdaoui MH.

Genet Mol Res. 2016 Apr 4;15(2). doi: 10.4238/gmr.15027487.

11.

Exploring an interaction of adenosine A2A receptor variability with coffee and tea intake in Parkinson's disease.

Tan EK, Lu ZY, Fook-Chong SM, Tan E, Shen H, Chua E, Yih Y, Teo YY, Zhao Y.

Am J Med Genet B Neuropsychiatr Genet. 2006 Sep 5;141B(6):634-6.

PMID:
16823803
12.

High coffee intake, but not caffeine, is associated with reduced estrogen receptor negative and postmenopausal breast cancer risk with no effect modification by CYP1A2 genotype.

Lowcock EC, Cotterchio M, Anderson LN, Boucher BA, El-Sohemy A.

Nutr Cancer. 2013;65(3):398-409. doi: 10.1080/01635581.2013.768348.

PMID:
23530639
13.

Dose-dependent protective effect of coffee, tea, and smoking in Parkinson's disease: a study in ethnic Chinese.

Tan EK, Tan C, Fook-Chong SM, Lum SY, Chai A, Chung H, Shen H, Zhao Y, Teoh ML, Yih Y, Pavanni R, Chandran VR, Wong MC.

J Neurol Sci. 2003 Dec 15;216(1):163-7.

PMID:
14607318
14.

Association of caffeine intake and CYP1A2 genotype with ovarian cancer.

Goodman MT, Tung KH, McDuffie K, Wilkens LR, Donlon TA.

Nutr Cancer. 2003;46(1):23-9.

PMID:
12925300
15.

Caffeine increases tear volume depending on polymorphisms within the adenosine A2a receptor gene and cytochrome P450 1A2.

Arita R, Yanagi Y, Honda N, Maeda S, Maeda K, Kuchiba A, Yamaguchi T, Yanagihara Y, Suzuki H, Amano S.

Ophthalmology. 2012 May;119(5):972-8. doi: 10.1016/j.ophtha.2011.11.033. Epub 2012 Feb 14.

PMID:
22336631
16.

The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers.

Kotsopoulos J, Ghadirian P, El-Sohemy A, Lynch HT, Snyder C, Daly M, Domchek S, Randall S, Karlan B, Zhang P, Zhang S, Sun P, Narod SA.

Cancer Epidemiol Biomarkers Prev. 2007 May;16(5):912-6.

17.

Associations between polymorphisms in the AHR and CYP1A1-CYP1A2 gene regions and habitual caffeine consumption.

Josse AR, Da Costa LA, Campos H, El-Sohemy A.

Am J Clin Nutr. 2012 Sep;96(3):665-71. doi: 10.3945/ajcn.112.038794. Epub 2012 Aug 1.

18.

Caffeine interaction with glutamate receptor gene GRIN2A: Parkinson's disease in Swedish population.

Yamada-Fowler N, Fredrikson M, Söderkvist P.

PLoS One. 2014 Jun 10;9(6):e99294. doi: 10.1371/journal.pone.0099294. eCollection 2014.

19.

Genetic susceptibility loci, environmental exposures, and Parkinson's disease: a case-control study of gene-environment interactions.

Chung SJ, Armasu SM, Anderson KJ, Biernacka JM, Lesnick TG, Rider DN, Cunningham JM, Ahlskog JE, Frigerio R, Maraganore DM.

Parkinsonism Relat Disord. 2013 Jun;19(6):595-9. doi: 10.1016/j.parkreldis.2013.02.008. Epub 2013 Mar 16.

20.

Combined effects of smoking, coffee, and NSAIDs on Parkinson's disease risk.

Powers KM, Kay DM, Factor SA, Zabetian CP, Higgins DS, Samii A, Nutt JG, Griffith A, Leis B, Roberts JW, Martinez ED, Montimurro JS, Checkoway H, Payami H.

Mov Disord. 2008 Jan;23(1):88-95.

PMID:
17987647

Supplemental Content

Support Center